Abbott lands a PMA win for its Absolute Pro stent, expanding its indication to treat patients with narrowing of the iliac arteries.
Abbott (NYSE:ABT) won expanded pre-market approval from the FDA for its Absolute Pro self-expanding stent system, according to an agency release.
The next-generation device, delivered via catheter, is now additionally indicated for use in narrowed iliac arteries.
Israeli medtech company Lumenis files for an initial public offering worth $115 million.
Indian media says its government is "dithering" on the controversy over Johnson & Johnson's...
Endologix is seeking to raise $75 million through sales of convertible notes with 2018 due dates.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
The FDA fines Ethicon's Advanced Sterilization Products business a total of $1.25 million over...